IP Verse

Novel Quinolone Derivatives - EP2935221

The patent EP2935221 was granted to Cadila Healthcare on Feb 7, 2018. The application was originally filed on Dec 23, 2013 under application number EP13828997A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".

EP2935221

CADILA HEALTHCARE
Application Number
EP13828997A
Filing Date
Dec 23, 2013
Status
No Opposition Filed Within Time Limit
Dec 14, 2018
Grant Date
Feb 7, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents